Lack of cytoprotective effect of amifostine following HLA-identical sibling transplantation for advanced myelodysplastic syndrome (MDS): a pilot study. [electronic resource]
Producer: 20040817Description: 1071-5 p. digitalISSN:- 0268-3369
- Adult
- Amifostine -- administration & dosage
- Busulfan -- administration & dosage
- Cause of Death
- Cytoprotection -- drug effects
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Humans
- Middle Aged
- Myeloablative Agonists -- administration & dosage
- Myelodysplastic Syndromes -- complications
- Pilot Projects
- Siblings
- Transplantation Conditioning -- adverse effects
- Transplantation, Homologous
- Treatment Outcome
- Whole-Body Irradiation
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.